Home Home > Browse Locations > Spain

Find Paid Clinical Trials in Spain

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in Spain

Top of Directory » All Locations » Spain


  • Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

    Conditions:   Hepatocellular Carcinoma;   Hepatitis C Virus Chronic Infection
    Intervention:   Biological: CP 675,206
    Sponsors:   Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra;   Pfizer
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified October 2009

  • Group Motivational Intervention in Overweight/Obese Patients

    Conditions:   Overweight;   Obesity
    Intervention:   Behavioral: Motivational intervention
    Sponsors:   Jordi Gol i Gurina Foundation;   Instituto de Salud Carlos III
    Recruiting - verified October 2009

  • Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection

    Condition:   Glioblastoma Multiforme
    Intervention:   Biological: autologous dendritic cells
    Sponsor:   Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra
    Recruiting - verified October 2009

  • A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

    Condition:   Pneumonia
    Interventions:   Drug: Amikacin (BAY41-6551);   Drug: Amikacin (BAY41-6551);   Drug: Placebo
    Sponsors:   Bayer;   Nektar Therapeutics
    Completed - verified October 2009

  • Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

    Conditions:   Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
    Intervention:   Drug: Pegylated interferon alfa-2a and Ribavirin
    Sponsor:   Sociedad Andaluza de Enfermedades Infecciosas
    Recruiting - verified October 2009

  • Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease

    Conditions:   Coronary Artery Disease;   Angioplasty, Transluminal, Percutaneous Coronary
    Intervention:   Device: Kaname cobalt-chromium coronary stent
    Sponsor:   Terumo Europe N.V.
    Not yet recruiting - verified October 2009

  • A Study of Pemetrexed and Bevacizumab for Patients With Advanced Non Small Cell Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified October 2009

  • Optimum Immunosuppression in Renal Transplant Recipients New Onset Diabetes After Transplantation

    Condition:   Diabetes Mellitus, Adult-Onset
    Interventions:   Drug: Tacrolimus with rapid steroid withdrawal;   Drug: Tacrolimus with steroids minimization;   Drug: CsA with steroid minimization
    Sponsor:   Fundación Canaria Rafael Clavijo para la Investigación Biomédica
    Not yet recruiting - verified October 2009

  • Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009

  • Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications

    Conditions:   Heart Valve Disease;   Aortic Stenosis
    Interventions:   Dietary Supplement: Phytine (phytate);   Dietary Supplement: Placebo
    Sponsors:   Hospital Universitari Son Dureta;   Laboratorios BIOMED SA
    Recruiting - verified October 2009

  • Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults

    Conditions:   Pneumococcal Vaccines;   HIV
    Intervention:   Biological: Prevenar and Pneumo23
    Sponsors:   Hospital Universitari Son Dureta;   Hospital Son Llatzer;   Fondo de Investigacion Sanitaria
    Recruiting - verified October 2009

  • A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Radiation: Thoracic Radiotherapy
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified October 2009

  • Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

    Condition:   HIV
    Interventions:   Drug: Atazanavir;   Drug: Atazanavir/Ritonavir;   Drug: Tenofovir/Emtricitabine
    Sponsor:   Bristol-Myers Squibb
    Active, not recruiting - verified October 2009

  • Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn`s Disease (ALOREVA)

    Conditions:   Rectovaginal Fistula;   Crohn Disease
    Intervention:   Drug: Expanded allogenic adipose-derived adult stem cells
    Sponsor:   Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
    Recruiting - verified October 2009

  • EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wildtype Metastatic Colorectal Cancer

    Condition:   Metastastic Colorectal Cancer
    Interventions:   Biological: EMD 525797, Irinotecan and Cetuximab;   Biological: EMD 525797, Irinotecan and Cetuximab;   Drug: Irinotecan and Cetuximab
    Sponsor:   EMD Serono
    Recruiting - verified November 2009

  • ADHEPTA Study: Adherence Questionnaire in Hepatitis C

    Conditions:   Hepatitis C, Chronic;   HIV Infection
    Intervention:   Other: Adherence questionnaire
    Sponsor:   IMS Health
    Recruiting - verified October 2009

  • Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis

    Condition:   Behcet Disease
    Interventions:   Biological: AIN457;   Biological: AIN457;   Biological: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

  • Quality of Life After Vertebroplasty Versus Conservative Treatment in Patients With Painful Osteoporotic Vertebral Fractures

    Conditions:   Spinal Fracture;   Osteoporosis;   Back Pain
    Interventions:   Procedure: percutaneous injection of cement into the vertebral body;   Other: Medical treatment
    Sponsors:   Hospital Clinic of Barcelona;   Sociedad Española de Radiologia Medica
    Active, not recruiting - verified October 2009

  • Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

    Condition:   HIV Infections
    Interventions:   Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
    Sponsor:   Germans Trias i Pujol Hospital
    Not yet recruiting - verified October 2009

  • Surgery for Esotropia Under Topical Anesthesia

    Condition:   Esotropia
    Interventions:   Procedure: Topical strabismus surgery;   Procedure: Sub-Tenon's strabismus surgery
    Sponsors:   Hospital Universitario Ramon y Cajal;   Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
    Recruiting - verified October 2009

  • Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

    Condition:   Arrhythmia Prophylaxis
    Interventions:   Drug: Celivarone (SSR149744);   Drug: amiodarone;   Drug: placebo
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009

  • A Open Label Clinical Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib (Tarceva®)

    Condition:   Carcinoma, Non-Small-Cell Lung
    Interventions:   Drug: BIBW 2992;   Drug: Sirolimus (rapamycin)
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials